The end of September is almost here. Will the DEA
Post# of 85499
https://thejointblog.com/marijuana-expected-t...-the-fall/
If rescheduling really does occur within 90 days of the FDA’s approval of Epidiolex, the change should happen by the end of September . The most likely scenario is that marijuana will be shifted to schedule 2, which means it’s still highly regulated but does have some medical value. Another possibility is that marijuana-derived CBD is rescheduled rather than marijuana as a whole, which would be a positive development, but less so.